Effect of chorioidic gonadotropin on the production and proliferative activity of regulatory subpopulations of thymocytes
Russian Journal of Immunology · 31.10.2026 · 29 (3) · 533-538
DOI: 10.46235/1028-7221-17422-eoc ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Journal of Immunology, online erschienen am 31.10.2026. Verfasst von O. L. Gorbunova. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chorionic gonadotropin (CG), being synthesized by the placenta, effectively regulates the functioning of both reproductive tissues and immune cells. Among the key mechanisms of immunological tolerance during gestation, one may consider the changing ratio of regulatory subgroups of T lymphocytes: interleukin-17-producing helper T lymphocytes (Th17), regulatory T lymphocytes (Treg), and invariant natural killer T lymphocytes (iNKT), which have both cytotoxic and immunoregulatory activity. The differentiation of these lymphocyte subtypes proceeds from the thymus gland. The aim of this study was to investigate the effect of hCG at a concentration typical for the 1st trimester of pregnancy, on the formation and proliferative activity of regulatory T cells (Th17, nTreg, iNKT) in thymocyte culture in vitro. The isolated thymocytes were cultured for 72 h with human gonadotropin (hCG) at a concentration of 100 IU/mL (I trimester of pregnancy), in the presence of CD3/CD28-activating particles. Subsequently, the subpopulation composition and proliferative activity of thymocytes were assessed using flow cytometry. Thymic natural (n)Tregs were defined as the percentage of CD4+CD25+FoxP3+ (Forkhead box P3) cells; Th17 cells were evaluated as the percentage of CD4+IL-17A+RORγt+ (retinoid-related orphan nuclear receptor) cells. The number of iNKT cells was determined as the percentage of CD3hiVa24Ja18+ cells in the thymocyte culture. The proliferative potential of nTreg, Th17, and iNKT cells was assessed by expression of the nuclear protein Ki-67 in the corresponding cell subpopulation, which is expressed throughout the cell cycle, except for the G0 phase. At the maximum concentration corresponding to the 1st trimester of pregnancy, HCG inhibits the differentiation of thymocytes stimulated by CD3/CD28 particles towards nTreg, while simultaneously activating their proliferative activity. At the same time, the hormone inhibits proliferation of thymic Th17 and iNKT cells, without affecting the formation of these cells. Against the background of TCR-activation of thymocytes, HCG at the contents corresponding to the 1st trimester of pregnancy, is capable to selectively regulate the proliferation processes among the precursors of regulatory T cell subpopulations in thymus gland. The hormone enhances the proliferative activity of nTreg thymocytes and inhibits it in Th17 and iNKT cells. The decreased levels of nTreg cells in the thymus under the influence of hHCG are apparently associated with activation of the cell cycle, since the induction of proliferation blocks the processes of differentiation. Thus, in the first trimester of pregnancy, CG enhances the processes of central immune tolerance, while simultaneously reducing the output of pro-inflammatory T lymphocytes.
Zitieren
APA
Gorbunova, O. L. (2026). Effect of chorioidic gonadotropin on the production and proliferative activity of regulatory subpopulations of thymocytes. Russian Journal of Immunology, 29(3), 533-538. https://doi.org/10.46235/1028-7221-17422-eoc
Vancouver
Gorbunova OL. Effect of chorioidic gonadotropin on the production and proliferative activity of regulatory subpopulations of thymocytes. Russian Journal of Immunology. 2026;29(3):533-538. doi:10.46235/1028-7221-17422-eoc
BibTeX
@article{Gorbunova2026,
author = {Gorbunova, O. L.},
title = {Effect of chorioidic gonadotropin on the production and proliferative activity of regulatory subpopulations of thymocytes},
journal = {Russian Journal of Immunology},
year = {2026},
volume = {29},
number = {3},
pages = {533--538},
doi = {10.46235/1028-7221-17422-eoc}
}
EUVIMED